Finoriq research workspace

XOMA Royalty Corp (XOMA) Historical Metrics

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland. Review XOMA valuation ratios, fundamentals, and filing metrics on Finoriq.

Company Snapshot

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Company

XOMA Royalty Corp (XOMA)

Ticker

XOMA

Market Cap

$503.8M

Latest Price

$40.17

Industry

Biotech & Pharma

Open insider transactions

XOMA Royalty Corp (XOMA) Current Valuation Metrics

Static valuation preview for XOMA Royalty Corp (XOMA). Market data retrieved 2026-07-09. Filing currency USD.

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.